Neonatal jaundice due to bruising
ICD-10 P58.0 is a billable code used to indicate a diagnosis of neonatal jaundice due to bruising.
Neonatal jaundice due to bruising is a condition characterized by the yellowing of the skin and sclera in newborns, resulting from the breakdown of red blood cells (hemolysis) following trauma or bruising during delivery. This condition is particularly common in infants who experience cephalohematoma or significant bruising due to assisted delivery methods such as vacuum extraction or forceps. The excessive hemolysis leads to an increase in bilirubin levels, which can result in jaundice. Clinically, jaundice typically appears within the first few days of life and may require monitoring and treatment, such as phototherapy, to prevent complications like kernicterus. The management of jaundice due to bruising involves careful assessment of bilirubin levels, identification of the underlying cause, and monitoring for any signs of severe hyperbilirubinemia. Understanding the etiology of jaundice in the context of bruising is crucial for effective treatment and management in the neonatal period.
Detailed documentation of the infant's birth history, including any trauma or bruising, and bilirubin levels.
Infants with cephalohematoma or significant bruising requiring NICU admission for jaundice management.
Consideration of phototherapy protocols and monitoring for potential complications.
Documentation of follow-up visits, bilirubin monitoring, and any interventions performed.
Pediatric follow-up for jaundice management in infants discharged from the NICU.
Awareness of developmental milestones and potential long-term effects of severe jaundice.
Used for obtaining bilirubin levels in jaundiced infants.
Document the reason for blood draw and bilirubin levels.
Neonatologists should ensure accurate tracking of bilirubin trends.
The primary cause is the breakdown of red blood cells due to bruising sustained during delivery, leading to elevated bilirubin levels.
